Compounds > propranolol
Page last updated: 2024-08-16

propranolol and doxapram

propranolol has been researched along with doxapram in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Glen, RC; Lowe, R; Mitchell, JB1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alexander, GA; Gay, GR; Kirkman, JH; Rappolt, RT1
Hatch, RC; Jernigan, AD1
Petty, WC; Sulkowski, TS1
Abe, Y; Endo, T; Kamada, N; Kobayashi, M; Ohno, H; Suzuki, Y1

Reviews

1 review(s) available for propranolol and doxapram

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for propranolol and doxapram

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Modification of cardiopressor and respirogenic effects of doxapram by propranolol.
    Clinical toxicology, 1978, Volume: 13, Issue:4

    Topics: Adult; Blood Pressure; Doxapram; Drug Interactions; Female; Heart Rate; Humans; Male; Propranolol; Respiration; Time Factors

1978
Effect of intravenously-administered putative and potential antagonists of ethanol on sleep time in ethanol-narcotized mice.
    Life sciences, 1988, Volume: 42, Issue:1

    Topics: 4-Aminopyridine; Alcoholic Intoxication; Aminophylline; Aminopyridines; Amphetamine; Animals; Azides; Benzodiazepines; Dextroamphetamine; Doxapram; Ethanol; Male; Mice; Naloxone; Physostigmine; Propranolol; Sleep; Thyrotropin-Releasing Hormone; Yohimbine

1988
CO 2 narcosis in the rat. II. Effects on the ECG.
    Aerospace medicine, 1971, Volume: 42, Issue:5

    Topics: Animals; Arrhythmias, Cardiac; Carbon Dioxide; Doxapram; Electrocardiography; Heart; Heart Block; Heart Rate; Hypercapnia; Hypoxia; Male; Potassium; Propranolol; Rats; Sodium; Time Factors

1971
Development and validation of an LC-MS/MS method for simultaneously determining doxapram and keto-doxapram in human serum.
    Bioanalysis, 2017, Volume: 9, Issue:6

    Topics: Calibration; Chromatography, Liquid; Doxapram; Drug Monitoring; Drug Stability; Humans; Limit of Detection; Propranolol; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry

2017